Reynders McVeigh Capital Management LLC lifted its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 13.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 560,733 shares of the technology company's stock after acquiring an additional 65,729 shares during the period. Relx accounts for about 1.3% of Reynders McVeigh Capital Management LLC's investment portfolio, making the stock its 29th largest position. Reynders McVeigh Capital Management LLC's holdings in Relx were worth $25,469,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of RELX. Private Trust Co. NA lifted its stake in shares of Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares in the last quarter. Sage Mountain Advisors LLC grew its stake in Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after buying an additional 258 shares during the period. DRW Securities LLC increased its position in shares of Relx by 5.9% in the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock worth $211,000 after acquiring an additional 259 shares in the last quarter. Peapack Gladstone Financial Corp raised its stake in shares of Relx by 5.7% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock valued at $234,000 after acquiring an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc lifted its holdings in shares of Relx by 1.3% during the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock valued at $1,190,000 after acquiring an additional 325 shares in the last quarter. 15.02% of the stock is owned by institutional investors and hedge funds.
Relx Stock Up 1.9 %
Shares of NYSE:RELX traded up $1.00 during trading on Friday, hitting $52.20. The company's stock had a trading volume of 718,471 shares, compared to its average volume of 717,339. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $52.54. The stock's 50-day moving average price is $49.35 and its two-hundred day moving average price is $47.97. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market capitalization of $96.61 billion, a PE ratio of 28.06, a PEG ratio of 2.73 and a beta of 0.84.
Relx Increases Dividend
The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is a boost from Relx's previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is 59.68%.
Analyst Ratings Changes
Several analysts recently issued reports on RELX shares. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. The Goldman Sachs Group began coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They set a "buy" rating on the stock. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Relx has a consensus rating of "Buy".
Get Our Latest Stock Report on RELX
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
